Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for ...
Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics: Allschwil, Switzerland Thursday, December 26, 202 ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
Chowhound on MSN21h
Is It Safe To Chomp On Ice From Restaurant Drinks?The next time you order an iced drink at a restaurant, ask yourself this: How safe are those ice cubes really, and how clean ...
The initial use of combination antimicrobial therapy for gram-negative infections is usually ... risk of superinfection with more-resistant bacteria or fungi. There are no clinical data that ...
India needs new drugs, improve infection control practices to thwart AMR: Dr Prabhu Vinayagam: Nandita Vijayasimha Bengaluru Monday, December 16, 2024, 08:00 Hrs [IST] India needs ...
Additional funding awarded following successful drug candidate nominationUSD 7.3 million to support progression of antibiotic BAL2420 (LptA inhibitor) towards first-in-human clinical studies Ad hoc ...
A new, highly drug-resistant strain of Shigella bacteria, causing severe diarrhea, has emerged in Los Angeles. Researchers at ...
Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, December 16, 2024Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a ...
Antimicrobial peptides (AMPs) have gained significant attention in scientific research due to their multifaceted roles in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback